Response to STRIDE: semaglutide in peripheral artery disease and type 2 diabetes

The Lancet 2026

View at publisher
Authors: Teba Alnima, Mark M Smits
DOI: 10.1016/s0140-6736(25)01632-0
Cited by: 0
References: 3

Fields of Study & Subjects

Peripheral Artery Disease Management Diabetes Treatment and Management Diabetes Cardiovascular Risks and Lipoproteins

Publication details

Journal / source
The Lancet
Volume
407
Issue
10528
Pages
573–573
Publication date
1 February 2026
Language
EN